BioXCell公司成立于1997年，总部位于美国，拥有逾25年的单克隆抗体和重组蛋白生产定制经验。公司致力于提供高纯度、低内毒素、无防腐剂的单克隆抗体，适用于体内临床前研究，堪称体内抗体领域的黄金标准。BioXCell专注于提供高品质、高效价、高纯度、高性价比的单克隆抗体，为用户提供全方位的抗体靶点和卓越服务。其中和、阻断和功能性抗体备受国际国内研究者推崇，在免疫、肿瘤学、神经科学等领域的研究中处于领先地位。BioXCell备受2018年诺贝尔生理学或医学奖得主James P. Allison 推崇，完美品质，值得信赖！点击代理授权书查看
| 中文名称 | 英文名称 | 产品货号 | 产品规格 |
| InVivoMAb抗小鼠CD11c | InVivoMAb anti-mouse CD11c | BXC-BE0038-1mg | 1 mg |
| InVivoMAb抗小鼠IL-27 p28 | InVivoMAb anti-mouse IL-27 p28 | BXC-BE0326-1mg | 1 mg |
| InVivoMAb抗犬CD34 | InVivoMAb anti-canine CD34 | BXC-BE0389-1mg | 1 mg |
| InvivoMAb抗犬PD-L1(B7-H1) | InVivoMAb anti-canine PD-L1 (B7-H1) | BXC-BE0390-1mg | 1 mg |
| InVivoMAb抗人MUC16 | InVivoMAb anti-human MUC16 | BXC-BE0391-1mg | 1 mg |
| InVivoMAb抗小鼠髓过氧化物酶(MPO) | InVivoMAb anti-mouse myeloperoxidase (MPO) | BXC-BE0392-1mg | 1 mg |
| InVivoMAb抗小鼠IL-25 | InVivoMAb anti-mouse IL-25 | BXC-BE0394-1mg | 1 mg |
| InVivoMAb抗小鼠/人Mac-2(半乳糖凝集素-3) | InVivoMAb anti-mouse/human Mac-2 (Galectin-3) | BXC-BE0395-1mg | 1 mg |
| InVivoMAb抗人/小鼠GRP 78 | InVivoMAb anti-human/mouse GRP78 | BXC-BE0396-1mg | 1 mg |
| InVivoMAb抗小鼠CD83 | InVivoMAb anti-mouse CD83 | BXC-BE0398-1mg | 1 mg |
| InVivoMAb抗小鼠VEGF-A | InVivoMAb anti-mouse VEGF-A | BXC-BE0399-1mg | 1 mg |
| InVivoMAb抗小鼠RGMb | InVivoMAb anti-mouse RGMb | BXC-BE0400-1mg | 1 mg |
| InVivoMAb抗人CEACAM5 | InVivoMAb anti-human CEACAM5 | BXC-BE0401-1mg | 1 mg |
| InVivoMAb抗人GPC-2 | InVivoMAb anti-human GPC-2 | BXC-BE0402-1mg | 1 mg |
| InVivoMAb抗小鼠CD96 | InVivoMAb anti-mouse CD96 | BXC-BE0403-1mg | 1 mg |
| InVivoMAb抗人GPC3 | InVivoMAb anti-human GPC3 | BXC-BE0404-1mg | 1 mg |
| InVivoMAb抗人间皮素 | InVivoMAb anti-human mesothelin | BXC-BE0405-1mg | 1 mg |
| InVivoMAb抗人CD2 | InVivoMAb anti-human CD2 | BXC-BE0406-1mg | 1 mg |
| InVivoMAb抗人Fy3 | InVivoMAb anti-human Fy3 | BXC-BE0407-1mg | 1 mg |
| InVivoMAb抗人TROP-2 | InVivoMAb anti-human TROP-2 | BXC-BE0408-1mg | 1 mg |
| InVivoMAb抗人BRCA 1 | InVivoMAb anti-human BRCA1 | BXC-BE0409-1mg | 1 mg |
| InVivoMAb抗人EphA2 | InVivoMAb anti-human EphA2 | BXC-BE0410-1mg | 1 mg |
| InVivoMAb抗人GC1q R(C1QBP) | InVivoMAb anti-human GC1q R (C1QBP) | BXC-BE0411-1mg | 1 mg |
| InVivoMAb抗人泛磷脂酰肌醇蛋白聚糖 | InVivoMAb anti-human pan-Glypican | BXC-BE0412-1mg | 1 mg |
| InVivoMAb抗大鼠TCR α/β | InVivoMAb anti-rat TCR α/β | BXC-BE0413-1mg | 1 mg |
| InVivoMAb抗鼠TCR γ/δ | InVivoMAb anti-rat TCR γ/δ | BXC-BE0414-1mg | 1 mg |
| InVivoMAb抗大鼠CD8α | InVivoMAb anti-rat CD8α | BXC-BE0415-5mg | 5 mg |
| InVivoMAb抗人/小鼠GRP 78 | InVivoMAb anti-human/mouse GRP78 | BXC-BE0416-1mg | 1 mg |
| InVivoMAb抗大鼠CD2 | InVivoMAb anti-rat CD2 | BXC-BE0417-1mg | 1 mg |
| InVivoMAb抗大鼠CD28 | InVivoMAb anti-rat CD28 | BXC-BE0418-1mg | 1 mg |
| InVivoMAb抗大鼠IL-4 | InVivoMAb anti-rat IL-4 | BXC-BE0419-1mg | 1 mg |
| InVivoMAb抗小鼠CD 205(DEC-205) | InVivoMAb anti-mouse CD205 (DEC-205) | BXC-BE0420-1mg | 1 mg |
| InVivoMAb抗基孔肯雅病毒E2 | InVivoMAb anti-chikungunya virus E2 | BXC-BE0421-1mg | 1 mg |
| InVivoMAb抗小鼠CD 86(B7-2) | InVivoMAb anti-mouse CD86 (B7-2) | BXC-BE0422-1mg | 1 mg |
| InVivoMAb抗小鼠VISTA | InVivoMAb anti-mouse VISTA | BXC-BE0423-1mg | 1 mg |
| InVivoMAb抗大鼠CTLA-4(CD 152) | InVivoMAb anti-rat CTLA-4 (CD152) | BXC-BE0424-1mg | 1 mg |
| InVivoMAb大鼠IgG 2b同种型对照，抗三硝基苯酚-匙孔血蓝蛋白 | InVivoMAb rat IgG2b isotype control, anti-trinitrophenol-keyhole limpet hemocyanin | BXC-BE0425-1mg | 1 mg |
| InVivoMAb抗小鼠树突状细胞标志物(33D1) | InVivoMAb anti-mouse Dendritic Cell Marker (33D1) | BXC-BE0426-1mg | 1 mg |
| 抗西尼罗病毒NS1 InVivoMAb | InVivoMAb anti-West Nile virus NS1 | BXC-BE0427-1mg | 1 mg |
| InVivoMAb抗小鼠CD 11b | InVivoMAb anti-mouse CD11b | BXC-BE0428-1mg | 1 mg |
| InVivoMAb抗WNV E蛋白DIII-LR | InVivoMAb anti-WNV E protein DIII-LR | BXC-BE0429-1mg | 1 mg |
| 抗WNV InvivoMAb和DI-DII蛋白质 | InVivoMAb anti-WNV E protein DI-DII | BXC-BE0430-1mg | 1 mg |
| InVivoMAb抗寨卡病毒E蛋白DIII-LR | InVivoMAb anti-Zika virus E protein DIII-LR | BXC-BE0431-1mg | 1 mg |
| InVivoMAb抗登革病毒2型E蛋白DIII | InVivoMAb anti-Dengue virus type 2 E protein DIII | BXC-BE0432-1mg | 1 mg |
| InVivoMAb抗东部马脑炎病毒E2蛋白 | InVivoMAb anti-Eastern equine encephalitis virus E2 protein | BXC-BE0433-1mg | 1 mg |
| InVivoMAb抗Powassan病毒E蛋白 | InVivoMAb anti-Powassan virus E protein | BXC-BE0434-1mg | 1 mg |
| InVivoMAb抗委内瑞拉马脑炎病毒E2蛋白 | InVivoMAb anti-Venezuelan equine encephalitis virus E2 protein | BXC-BE0435-1mg | 1 mg |
| InVivoMAb抗人VISTA | InVivoMAb anti-human VISTA | BXC-BE0436-1mg | 1 mg |
| InVivoMAb抗登革病毒4型E蛋白DIII | InVivoMAb anti-Dengue virus type 4 E protein DIII | BXC-BE0437-1mg | 1 mg |
| InVivoMAb抗SARS-CoV-2 S蛋白(RBD) | InVivoMAb anti-SARS-CoV-2 S protein (RBD) | BXC-BE0438-1mg | 1 mg |
| InVivoMAb抗大鼠CD4 | InVivoMAb anti-rat CD4 | BXC-BE0439-1mg | 1 mg |
| InVivoMAb抗鼠标CXCL 10(IP-10) | InVivoMAb anti-mouse CXCL10 (IP-10) | BXC-BE0440-1mg | 1 mg |
| InVivoMAb抗人IL-10 | InVivoMAb anti-human IL-10 | BXC-BE0441-1mg | 1 mg |
| InVivoPlus小鼠IgG2c同种型对照，抗登革热病毒 | InVivoPlus mouse IgG2c isotype control, anti-dengue virus | BXC-BP0366-5mg | 5 mg |
| RecombiMAb抗小鼠PD-L1(B7-H1)(D265 A) | RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A) | BXC-CP001-1mg | 1 mg |
| RecombiMAb抗小鼠PD-1(CD 279)(D265 A) | RecombiMAb anti-mouse PD-1 (CD279) (D265A) | BXC-CP002-1mg | 1 mg |
| RecombiMAb抗小鼠PD-1(CD 279)(D265 A) | RecombiMAb anti-mouse PD-1 (CD279) (D265A) | BXC-CP005-1mg | 1 mg |
| RecombiMAb抗小鼠CTLA-4(CD 152) | RecombiMAb anti-mouse CTLA-4 (CD152) | BXC-CP006-1mg | 1 mg |
| RecombiMAb抗小鼠CTLA-4(CD 152)(LALA-PG) | RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG) | BXC-CP008-1mg | 1 mg |
| RecombiMAb抗鼠标LAG-3(D265 A) | RecombiMAb anti-mouse LAG-3 (D265A) | BXC-CP013-1mg | 1 mg |
| RecombiMAb抗小鼠LAG-3 | RecombiMAb anti-mouse LAG-3 | BXC-CP014-1mg | 1 mg |
| RecombiMAb抗小鼠OX40(CD134) | RecombiMAb anti-mouse OX40 (CD134) | BXC-CP017-1mg | 1 mg |
| RecombiMAb抗小鼠OX 40(CD 134)(LALA-PG) | RecombiMAb anti-mouse OX40 (CD134) (LALA-PG) | BXC-CP018-1mg | 1 mg |
| RecombiMAb抗小鼠CD 16/CD 32 | RecombiMAb anti-mouse CD16/CD32 | BXC-CP025-1mg | 1 mg |
| RecombiMAb抗鼠标CD 16/CD 32(LALA-PG) | RecombiMAb anti-mouse CD16/CD32 (LALA-PG) | BXC-CP026-1mg | 1 mg |
| RecombiMAb抗小鼠GITR(D265A) | RecombiMAb anti-mouse GITR (D265A) | BXC-CP027-1mg | 1 mg |
| RecombiMAb抗小鼠GITR | RecombiMAb anti-mouse GITR | BXC-CP028-1mg | 1 mg |
| RecombiMAb抗小鼠GITR(LALA-PG) | RecombiMAb anti-mouse GITR (LALA-PG) | BXC-CP029-1mg | 1 mg |
| RecombiMAb抗鼠标CD 40 L(CD 154)(D265 A) | RecombiMAb anti-mouse CD40L (CD154) (D265A) | BXC-CP032-1mg | 1 mg |
| RecombiMAb抗小鼠4-1BB(CD 137)(LALA-PG) | RecombiMAb anti-mouse 4-1BB (CD137) (LALA-PG) | BXC-CP038-1mg | 1 mg |
| RecombiMAb抗小鼠ICOSL(CD275)(D265A) | RecombiMAb anti-mouse ICOSL (CD275) (D265A) | BXC-CP044-1mg | 1 mg |
| RecombiMAb小鼠IgG1(D265A)同种型对照，抗鸡蛋溶菌酶 | RecombiMAb mouse IgG1 (D265A) isotype control, anti-hen egg lysozyme | BXC-CP047-1mg | 1 mg |
| RecombiMAb小鼠IgG 2a(LALA-PG)同种型对照，抗鸡蛋溶菌酶 | RecombiMAb mouse IgG2a (LALA-PG) isotype control, anti-hen egg lysozyme | BXC-CP048-1mg | 1 mg |
| RecombiMAb抗小鼠CD71(TfR1) | RecombiMAb anti-mouse CD71 (TfR1) | BXC-CP130-1mg | 1 mg |
| RecombiMAb抗小鼠CSF1R(CD115) | RecombiMAb anti-mouse CSF1R (CD115) | BXC-CP131-1mg | 1 mg |
| RecombiMAb抗小鼠VEGFR-2 | RecombiMAb anti-mouse VEGFR-2 | BXC-CP132-1mg | 1 mg |
| RecombiMAb抗小鼠CD40 | RecombiMAb anti-mouse CD40 | BXC-CP133-1mg | 1 mg |
| RecombiMAb抗小鼠CD8α | RecombiMAb anti-mouse CD8α | BXC-CP134-1mg | 1 mg |
| RecombiMAb抗小鼠Ly 6 G/Ly 6C(Gr-1) | RecombiMAb anti-mouse Ly6G/Ly6C (Gr-1) | BXC-CP135-1mg | 1 mg |
| RecombiMAb抗小鼠PD-L1(B7-H1)(LALA-PG) | RecombiMAb anti-mouse PD-L1 (B7-H1) (LALA-PG) | BXC-CP154-1mg | 1 mg |
| RecombiMAb抗小鼠PD-1(CD 279)(LALA-PG) | RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG) | BXC-CP155-1mg | 1 mg |
| RecombiMAb小鼠IgG 2a(LALA-PG)同种型对照，特异性未知 | RecombiMAb mouse IgG2a (LALA-PG) isotype control, unknown specificity | BXC-CP156-1mg | 1 mg |
| RecombiMAb抗小鼠PD-L1(B7-H1) | RecombiMAb anti-mouse PD-L1 (B7-H1) | BXC-CP158-1mg | 1 mg |
| RecombiMAb人IgG1(N297A)同种型对照，抗鸡蛋溶菌酶 | RecombiMAb human IgG1 (N297A) isotype control, anti-hen egg lysozyme | BXC-CP171-1mg | 1 mg |
| RecombiMAb抗小鼠Ly 6 G/Ly 6C(Gr-1) | RecombiMAb anti-mouse Ly6G/Ly6C (Gr-1) | BXC-CP172-1mg | 1 mg |
| RecombiMAb人IgG1(D265A)同种型对照，抗鸡蛋溶菌酶 | RecombiMAb human IgG1 (D265A) isotype control, anti-hen egg lysozyme | BXC-CP173-1mg | 1 mg |
| RecombiMAb人IgG1同种型对照，抗鸡蛋溶菌酶 | RecombiMAb human IgG1 isotype control, anti-hen egg lysozyme | BXC-CP174-1mg | 1 mg |
| RecombiMAb人IgG 1(K214 R/L234 F/L235 E/P331 S)同种型对照，抗鸡蛋溶菌酶 | RecombiMAb human IgG1 (K214R/L234F/L235E/P331S) isotype control, anti-hen egg lysozyme | BXC-CP175-1mg | 1 mg |
| RecombiMAb HIS人IgG1 F(ab)同种型对照，抗鸡蛋溶菌酶 | RecombiMAb HIS human IgG1 F(ab) isotype control, anti-hen egg lysozyme | BXC-CP179-1mg | 1 mg |
| RecombiMAb人IgG2同种型对照，抗鸡蛋溶菌酶 | RecombiMAb human IgG2 isotype control, anti-hen egg lysozyme | BXC-CP180-1mg | 1 mg |
| RecombiMAb人IgG4(S228P)同种型对照，抗鸡蛋溶菌酶 | RecombiMAb human IgG4 (S228P) isotype control, anti-hen egg lysozyme | BXC-CP181-1mg | 1 mg |
| ReadyTag抗c-myc | ReadyTag anti-c-myc | BXC-RT0263-1mg | 1 mg |
| ReadyTag抗GST | ReadyTag anti-GST | BXC-RT0264-1mg | 1 mg |
| ReadyTag抗GFP | ReadyTag anti-GFP | BXC-RT0265-1mg | 1 mg |
| ReadyTag抗6-His | ReadyTag anti-6-His | BXC-RT0266-1mg | 1 mg |
| ReadyTag抗OVA | ReadyTag anti-OVA | BXC-RT0267-1mg | 1 mg |
| ReadyTag抗HA | ReadyTag anti-HA | BXC-RT0268-1mg | 1 mg |
| ReadyTag抗DDDDK | ReadyTag anti-DDDDK | BXC-RT0269-1mg | 1 mg |
| InVivoSIM抗人IFNAR1(Anifrolumab生物仿制药) | InVivoSIM anti-human IFNAR1 (Anifrolumab Biosimilar) | BXC-SIM0022-1mg | 1 mg |
| InVivoSIM抗人IL-4 R α(CD 124)(Dupilumab生物仿制药) | InVivoSIM anti-human IL-4Rα (CD124) (Dupilumab Biosimilar) | BXC-SIM0023-1mg | 1 mg |
| InVivoSIM抗人整联蛋白α4β7(LPAM-1)(Vedolizumab生物仿制药) | InVivoSIM anti-human integrin α4β7 (LPAM-1) (Vedolizumab Biosimilar) | BXC-SIM0024-1mg | 1 mg |
| InVivoSIM抗人IL-23(p19)(Guselkumab生物仿制药) | InVivoSIM anti-human IL-23 (p19) (Guselkumab Biosimilar) | BXC-SIM0025-1mg | 1 mg |
| InVivoSIM抗人Claudin 18.2(唑贝妥昔单抗生物仿制药) | InVivoSIM anti-human Claudin 18.2 (Zolbetuximab Biosimilar) | BXC-SIM0026-1mg | 1 mg |
| InVivoSIM抗人PD-L1(Durvalumab生物仿制药) | InVivoSIM anti-human PD-L1 (Durvalumab Biosimilar) | BXC-SIM0027-1mg | 1 mg |
| InVivoSIM抗人RANKL(CD254)(Denosumab生物仿制药) | InVivoSIM anti-human RANKL (CD254) (Denosumab Biosimilar) | BXC-SIM0028-1mg | 1 mg |
| InVivoSIM抗人IL-17 A(Ixekizumab生物仿制药) | InVivoSIM anti-human IL-17A (Ixekizumab Biosimilar) | BXC-SIM0029-1mg | 1 mg |
| InVivoSIM抗人IL-6(Siltuximab生物仿制药) | InVivoSIM anti-human IL-6 (Siltuximab Biosimilar) | BXC-SIM0030-1mg | 1 mg |
| InVivoSIM抗人nectin-4(Enfortumab生物仿制药) | InVivoSIM anti-human nectin-4 (Enfortumab Biosimilar) | BXC-SIM0031-1mg | 1 mg |
| InVivoSIM抗人β淀粉样蛋白(Lecanemab生物仿制药) | InVivoSIM anti-human amyloid-beta (Lecanemab Biosimilar) | BXC-SIM0032-1mg | 1 mg |
| InVivoSIM抗人TIGIT(替拉格单抗生物仿制药) | InVivoSIM anti-human TIGIT (Tiragolumab Biosimilar) | BXC-SIM0033-1mg | 1 mg |
| InVivoSIM抗人CD38(达雷妥尤单抗生物仿制药) | InVivoSIM anti-human CD38 (Daratumumab Biosimilar) | BXC-SIM0034-1mg | 1 mg |
| InvivoSIM抗人CD 25(IL-2 R α)(Daclizumab生物仿制药) | InVivoSIM anti-human CD25 (IL-2Rα) (Daclizumab Biosimilar) | BXC-SIM0035-1mg | 1 mg |
| InVivoSIM抗人TSLP(Tezepelumab生物仿制药) | InVivoSIM anti-human TSLP (Tezepelumab Biosimilar) | BXC-SIM0036-1mg | 1 mg |
| InVivoSIM抗人PD-1(Cemiplimab生物仿制药) | InVivoSIM anti-human PD-1 (Cemiplimab Biosimilar) | BXC-SIM0037-1mg | 1 mg |
| InVivoSIM抗人PD-1(Tislelizumab生物仿制药) | InVivoSIM anti-human PD-1 (Tislelizumab Biosimilar) | BXC-SIM0038-1mg | 1 mg |
